Posts by: Margarida Azevedo, MSc

Margarida Azevedo, MSc

Margarida graduated with a BS in Health Sciences from the University of Lisbon and a MSc in Biotechnology from Instituto Superior Técnico (IST-UL). She worked as a molecular biologist research associate at a Cambridge UK-based biotech company that discovers and develops therapeutic, fully human monoclonal antibodies.

May 20, 2016May 20, 2016

Europe’s Pain Experts to Gather in Brussels for ‘Societal Impact of Pain’ Symposium

News

The European Pain Federation (EFIC) and partners will highlight the socioeconomic burdens and policy solutions of chronic pain, at the 6th European Symposium ‘Societal Impact of Pain (SIP 2016): Time ... Read more

May 11, 2016May 11, 2016

NAPW Honors Member For Work With Fibromyalgia, Chronic Pain

News

The National Association of Professional Women (NAPW), the nation’s leading networking association fully dedicated to professional women, has honored Deb Lundquist as a 2016-2017 inductee into its VIP Woman of the Year Circle. ... Read more

May 9, 2016May 9, 2016

National Fibromyalgia & Chronic Pain Association Funds Research and Sponsors ‘Together Walks’

News

After the U.S. Centers for Disease Control (CDC) published its Guidelines for Prescribing Opioids 2016 in March 15, 2016, restricting access to opioid medications, the National Fibromyalgia & Chronic Pain Association (NFMCPA), an ... Read more

May 4, 2016May 19, 2016

Tonix Pharmaceuticals Completes Enrollment in Fibromyalgia Phase 3 Clinical Trial

News

Tonix Pharmaceuticals, a company developing next-gen therapies for disorders of the central nervous system, including fibromyalgia and post-traumatic stress disorder (PTSD), has completed enrollment in its Phase 3 AFFIRM clinical trial of TNX-102 ... Read more

April 15, 2016April 15, 2016

Researchers Map Full-length Protein Involved in Chronic Pain, with Hopes for Future Therapies

News

Case Western Reserve University School of Medicine researchers have discovered the full-length structure of a protein named Transient Receptor Potential Vanilloid subtype 2 (TRPV2), with implications for the development of new treatments ... Read more

April 12, 2016April 13, 2016

NSAIDs Survey Offers Some Surprising Answers from Pain Patients

News

Data from a survey of 1,056 Americans, funded by Iroko Pharmaceuticals, indicated that 77 percent experienced at least some type of pain, 43 percent experienced pain every week, and half were unfamiliar with nonsteroidal ... Read more

March 30, 2016May 19, 2016

Tonix to Present Programs for PTSD, Fibromyalgia Drug Candidate at European Conference

News

Tonix Pharmaceuticals, a company dedicated to developing next-gen medicines for fibromyalgia and post-traumatic stress disorder (PTSD), announced its Executive Vice President of Commercial Planning and Development, Ronald Notvest, Ph.D., MBA, will present at the ... Read more

March 22, 2016March 22, 2016

Fibromyalgia Pain, Fatigue Greatly Affect Perceptions of Physical Ability, Study Finds

News

Fibromyalgia-related pain and fatigue can explain much of the variance found in patients’ perceptions of their physical performance and abilities, according to a study, “Perceived function and physical performance are associated ... Read more

March 16, 2016May 19, 2016

Orthogonal Treatment for Fibromyalgia, Other Painful Conditions Now Offered in Lindenhurst, Ill.

News

People with fibromyalgia and other painful conditions who live in and around Lindenhurst, Illinois, now have another option to help them realign their spine and re-set their body’s health. Natural Care Chiropractic ... Read more

March 14, 2016May 19, 2016

Encouraging Potential Treatment Data for Fibromyalgia, PTSD Presented by Tonix Pharmaceuticals

News

Tonix Pharmaceuticals has presented data for TNX-102 SL (cyclobenzaprine HCI sublingual tablets, 2.8 mg), its investigational new drug, at the American Society for Clinical Pharmacology and Therapeutics 2016 Annual Meeting, held March ... Read more